Malnutrition. Retarded development following protein-calorie malnutrition
Conditions
Interventions
Intervention 1: Intervention group: Group receiving RUTF (S0000250) dietary supplement. Intervention 2: Intervention group: Nutrition education recipient group. Intervention 3: Intervention group: Gro
Sponsors
United Nations Children's Fund
Eligibility
Sex/Gender
All
Age
7 Years to 15 Years
Inclusion criteria
Inclusion criteria: Willingness to cooperate Children and adolescents aged 7-15 Being thin or short (body mass index or weight for age < Z score -2 and height for age < Z score -2) No underlying diseases affecting physical growth such as genetic disorders, growth hormone disorders, hyperthyroidism, chronic gastrointestinal, liver, kidney, cardiovascular disease, neurological problems affecting food intake and cancer based on questions from the individual and the caregiver No taking nutritional supplements and multivitamin-mineral supplements in the past 6 months No taking medications affecting growth hormone metabolism and weight loss medications
Exclusion criteria
Exclusion criteria: Unwillingness to cooperate in any of the stages of the study Diagnosis of any type of disease: growth hormone disorders, hyperthyroidism, chronic gastrointestinal, hepatic, renal, cardiovascular diseases, neurological problems affecting food intake and cancer during the study Use of drugs affecting growth hormone metabolism and weight loss drugs during the study Failure to comply with intervention programs by at least 70% of the expected amount (4 months of biscuit consumption or at least 4 training sessions) Sampling method
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Body mass index. Timepoint: Assessment of children's body mass index at baseline (before the start of the intervention) and at the end of the third and sixth months of the intervention. Method of measurement: Ratio of weight (kilograms) to the square of height (meters).;Weight. Timepoint: Assessment of children's body weight at baseline (before the start of the intervention) and at the end of the third and sixth months of the intervention. Method of measurement: A person's weight based on Earth's gravity using a digital scale.;Height. Timepoint: Assessment of children's height at baseline (before the start of the intervention) and at the end of the third and sixth months of the intervention. Method of measurement: A person's height in a standing position using a height gauge.;Waist circumference. Timepoint: Assessment of waist circumference at baseline (before the start of the intervention) and at the end of the third and sixth months of the intervention. Method of measurement: Tape measure. | — |
Secondary
| Measure | Time frame |
|---|---|
| Mental concentration index. Timepoint: Assessment of mental concentration index at the beginning of the study (before the intervention) and at the end of the third and sixth months. Method of measurement: Toulouse-Pyron test.;Short-term memory index. Timepoint: Evaluation of short-term memory index at the beginning of the study (before the start of the intervention) and at the end of the third and sixth months. Method of measurement: Numerical learning test. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactMohammad Reza Vafa
Iran University of Medical Sciences
Outcome results
None listed